Skip to content
★ Sign in to follow
Insider activity · 24 months3 buys4 salesCumulative net flow
Total declarations
23
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€254k

Latest filing published 19 Sept 2025 for Dr. Lal Path Labs Ltd., €18k.

Filing timeline

BuySale
Amit Aggarwal

Amit Aggarwal: trading record in brief

Amit Aggarwal is a declared insider of Dr. Lal Path Labs Ltd., with filings sourced from SEBI (PIT + SAST). The record holds 23 filings, for trades running from 26 September 2022 to 19 September 2025.

No open-market purchase appears, only 16 sales worth €254k. The rest of the record consists of 7 share grants. Since January 2025: no purchases and 4 sales on the market.

The newest entry dates from 19 September 2025: an open-market sale of €18k, in Dr. Lal Path Labs Ltd. Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Amit Aggarwal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR3SEBI
    550 shares@ ₹3,433.31826.0% of flowEquity SharesSEBI:00ac299484cf4b6b969835540ed0a28d184eafa2
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR2SEBI
    750 shares@ ₹2,093.31074.9% of flowEquity SharesSEBI:8ef3300087bc2371e6d04c37c8e24dfb1850dc5c
    Canonical exit: 18 Dec 2025 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    500,550 INR2SEBI
    150 shares@ ₹3,337.001.6% of flowEquity SharesSEBI:5399ba4e2761d1d03e5146d7a7a246590182d9ed
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    510,000 INR2SEBI
    150 shares@ ₹3,400.001.6% of flowEquity SharesSEBI:5d032cac5dbf51c045a4e159fc0ab4a83b21aa34
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    482,513 INR2SEBI
    250 shares@ ₹1,930.0521.5% of flowEquity SharesSEBI:858fdf5adb68ced1ae0289567728a3b7fe7cea43
    Canonical exit: 20 Nov 2025 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    947,875 INR2SEBI
    275 shares@ ₹3,446.81823.0% of flowEquity SharesSEBI:832c4ae9aefbafa55d2af31719bafa2346381278
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    8,750 INR2SEBI
    875 shares@ ₹10.000.0% of flowEquity SharesSEBI:fe8f466acd1d5edeb97341be36bb1cbe464ec973
    Canonical exit: 6 Nov 2025 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR3SEBI
    500 shares@ ₹3,296.805.8% of flowEquity SharesSEBI:4d2e12f233475d3549cafd6afe2b10a7c47eddc4
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    965,025 INR2SEBI
    500 shares@ ₹1,930.053.4% of flowEquity SharesSEBI:4b1a9c3758024b26b93e5769afc534fb658646b5
    Canonical exit: 16 Dec 2024 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR3SEBI
    500 shares@ ₹3,430.006.0% of flowEquity SharesSEBI:61dfeaf42db4fd0042e3e62aff760d4f673f28ee
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR3SEBI
    500 shares@ ₹3,412.206.0% of flowEquity SharesSEBI:d806254d92f24cd28c9261a04c618bde6b793252
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    1M INR2SEBI
    400 shares@ ₹3,385.504.7% of flowEquity SharesSEBI:71bd1c8576dc1072a710917028174844e9329a72
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR3SEBI
    1,000 shares@ ₹2,052.4957.2% of flowEquity SharesSEBI:030185f55dd94170820edf29372baec51a4cb9c8
    Canonical exit: 3 Dec 2024 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    1M INR2SEBI
    400 shares@ ₹3,417.504.8% of flowEquity SharesSEBI:a2d484e070cf7a4a6ab278be598a6ea82dd7bc64
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    1M INR2SEBI
    400 shares@ ₹3,340.254.7% of flowEquity SharesSEBI:3f88ac10b5eaf3815c3cec596e5f4a05b58cd01f
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    3M INR3SEBI
    1,000 shares@ ₹3,269.2511.5% of flowEquity SharesSEBI:c092ef2d6730b6935be5af1349afdf4f98b9a20c
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    659,000 INR2SEBI
    200 shares@ ₹3,295.002.3% of flowEquity SharesSEBI:c6329bf519b850431adb7bc5cd9d904d69b11780
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    22,000 INR2SEBI
    2,200 shares@ ₹10.000.1% of flowEquity SharesSEBI:11f9995b8116946e02633e288c9464ee576a269f
    Canonical exit: 11 Nov 2024 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    3M INR3SEBI
    1,000 shares@ ₹2,746.12910.0% of flowEquity SharesSEBI:198e551f2c35e2d6b5b09423dbd434fe56cdd429
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    2M INR3SEBI
    600 shares@ ₹2,710.605.9% of flowEquity SharesSEBI:d7587c94100c6cd323f7800a6c291ea38c26bd38
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    1M INR2SEBI
    400 shares@ ₹2,716.254.0% of flowEquity SharesSEBI:8818390549daab48c2d39b224cff31e94c8120a9
  • ▲
    ExecutivesDr. Lal Path Labs Ltd.
    7,000 INR2SEBI
    700 shares@ ₹10.000.0% of flowEquity SharesSEBI:20480614b346599ca565d28d3cfac519b8ec441e
    Canonical exit: 6 Apr 2023 (T+90)
  • ▼
    ExecutivesDr. Lal Path Labs Ltd.
    1M INR2SEBI
    475 shares@ ₹2,562.10535.0% of flowEquity SharesSEBI:c76e5763b26520072b7c916070648c20fb298b8d

23 of 23 declarations